ALKINDI

This brand name is authorized in Austria, Estonia, Croatia, Ireland, Israel, Lithuania, Poland, Romania, United Kingdom

Active ingredients

The drug ALKINDI contains one active pharmaceutical ingredient (API):

1 Hydrocortisone UNII WI4X0X7BPJ - HYDROCORTISONE

Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates. Read about Hydrocortisone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ALKINDI Granule in capsule	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H02AB09	Hydrocortisone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1764525, 1764536, 1764547, 1764558
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 356978, 356995, 357001, 357005
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9082, 9083, 9084, 9085
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1085086, 1085087, 1085088, 1085089
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100402072, 100402089, 100402095, 100402103
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68176001, W68177001, W68178001, W68179001